“…The use of evidence-based treatments appears to be imbalanced according to patient gender. In particular, in female patients, a decreased use of ACE-inhibitors, angiotensin-receptor blockers or beta-blockers, lower achieved doses, a lower access to invasive procedure, such as coronary angiography or revascularization and implantation of devices (implantable cardioverter defibrillators or biventricular pacemakers), have been frequently reported [11][12][13][14]. Thus, genderrelated differences in medical treatment could influence quality of life and survival of female compared to male patients.…”